BRIDGEBIO PHARMA INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 2.250% 2/0, CUSIP 10806XAD4.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 2.250% 2/0, CUSIP 10806XAD4.